12/18/23 17:09 | 12/14/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 2 | 19 | 13 | D | | | | | | | | | | | | | | |
6/27/23 16:31 | 6/25/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 1 | 6 | 15 | D | | | | | | | | | | | | | | |
3/14/23 17:18 | 3/10/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 30 | 6.52 | 0 | 5 | 46 | 15 | D | | | | | | | | | | | | | | |
12/16/22 17:02 | 12/14/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 2 | 22 | 12 | D | | | | | | | | | | | | | | |
9/28/22 17:00 | 9/26/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 5 | 80 | 10 | M | | | | | | | | | | | | | | |
8/26/22 18:42 | 8/24/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 2 | 37 | 7 | I | | | | | | | | | | | | | | |
6/28/22 17:05 | 6/25/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 1 | 16 | 6 | D | | | | | | | | | | | | | | |
1/5/22 17:22 | 1/3/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | 845 | 6 | D | | | | | | | | | | | | | | |
1/5/22 17:22 | 1/3/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -705 | 140.91 | 0 | -5 | -47 | 6 | D | | | | | | | | | | | | | | |
12/22/21 17:03 | 12/20/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | 845 | 6 | D | | | | | | | | | | | | | | |
12/22/21 17:03 | 12/20/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,150 | 230.00 | 0 | -5 | -47 | 6 | D | | | | | | | | | | | | | | |
12/16/21 17:16 | 12/14/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 2 | 60 | 6 | D | | | | | | | | | | | | | | |
12/3/21 18:30 | 12/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
12/3/21 18:30 | 12/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -981 | 196.19 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
12/1/21 17:02 | 11/29/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
12/1/21 17:02 | 11/29/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,144 | 228.72 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
11/5/21 17:02 | 11/3/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
11/5/21 17:02 | 11/3/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,000 | 200.00 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
11/3/21 16:49 | 11/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
11/3/21 16:49 | 11/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -815 | 163.08 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
10/5/21 17:02 | 10/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
10/5/21 17:02 | 10/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -874 | 174.89 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
9/28/21 17:04 | 9/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 5 | | 5 | M | | | | | | | | | | | | | | |
9/24/21 17:08 | 8/24/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 2 | 999% | 2 | I | | | | | | | | | | | | | | |
9/17/21 17:11 | 9/15/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
9/17/21 17:11 | 9/15/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,147 | 229.44 | 0 | -5 | -88 | 1 | D | | | | | | | | | | | | | | |
9/3/21 17:10 | 9/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 95 | 19.08 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
9/3/21 17:10 | 9/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,240 | 247.97 | 0 | -5 | -88 | 1 | D | | | | | | | | | | | | | | |
7/28/21 17:00 | 7/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.83 | 0 | 3 | | 1 | D | | | | | | | | | | | | | | |
7/28/21 17:00 | 7/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -573 | 197.74 | 0 | -3 | -80 | 1 | D | | | | | | | | | | | | | | |
7/2/21 17:01 | 6/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.83 | 0 | 3 | | 1 | D | | | | | | | | | | | | | | |
7/2/21 17:01 | 6/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -616 | 212.66 | 0 | -3 | -80 | 1 | D | | | | | | | | | | | | | | |
6/29/21 17:08 | 6/25/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
6/2/21 16:59 | 5/28/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.83 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
6/2/21 16:59 | 5/28/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -432 | 149.14 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
5/4/21 18:03 | 4/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.82 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
5/4/21 18:03 | 4/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -694 | 239.83 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
3/30/21 18:10 | 3/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.82 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
3/30/21 18:10 | 3/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -541 | 186.80 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
3/2/21 17:37 | 2/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 43 | 14.82 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
3/2/21 17:37 | 2/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -653 | 225.48 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
2/3/21 17:37 | 2/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 273 | 18.15 | 0 | 15 | | 0 | D | | | | | | | | | | | | | | |
2/3/21 17:37 | 2/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -3,628 | 241.50 | 0 | -15 | -98 | 0 | D | | | | | | | | | | | | | | |
9/30/20 21:30 | 9/28/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 147 | 5.95 | 0 | 25 | | 0 | D | | | | | | | | | | | | | | |
9/30/20 21:30 | 9/28/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.dm | -4,665 | 109.04 | 0 | -43 | -99 | 0 | D | | | | | | | | | | | | | | |
9/29/20 18:11 | 9/26/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 0 | 0.00 | 0 | 35 | | 18 | D | | | | | | | | | | | | | | |
8/20/20 18:20 | 8/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | M.d | 2,489 | 53.82 | 0 | 46 | | 0 | D | | | | | | | | | | | | | | |
8/20/20 18:20 | 8/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -6,674 | 144.33 | 0 | -46 | -99 | 0 | D | | | | | | | | | | | | | | |
5/20/20 16:35 | 5/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | M.d | 339 | 26.19 | 0 | 13 | | 0 | D | | | | | | | | | | | | | | |
5/20/20 16:35 | 5/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S.d | -641 | 49.44 | 0 | -13 | -98 | 0 | D | | | | | | | | | | | | | | |
3/10/20 17:02 | 3/8/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | M.d | 0 | 0.00 | 0 | 0 | | 0 | D | | | | | | | | | | | | | | |
9/18/19 16:14 | 9/17/19 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S | -26 | 7.07 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
9/10/19 16:34 | 9/8/19 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | M.d | 0 | 0.00 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
2/2/17 16:12 | 1/31/17 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | P | 6 | 1.12 | 8 | 5 | 235 | 7 | D | -83 | -72 | -82 | -14 | -7 | -4 | -4 | -2 | 4 | 2 | 15 | -38 | | |
2/1/16 17:37 | 1/31/16 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | P | 9 | 4.38 | 33 | 2 | 999% | 2 | D | -10 | -34 | -57 | -30 | -41 | -27 | -17 | -9 | -7 | -4 | -7 | 4 | 44 | -73 |
12/18/15 17:10 | 12/16/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S | -241 | 8.64 | 33 | -28 | -100 | 0 | D | 94 | 47 | -8 | -18 | 11 | 11 | 5 | 17 | 1 | -1 | -27 | -38 | -20 | -82 |
8/4/15 16:49 | 7/31/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | P | 3 | 2.28 | 33 | 2 | 6 | 28 | D | 352 | 184 | 57 | 51 | 22 | 0 | 1 | 2 | 2 | -5 | -10 | -41 | -58 | -38 |
2/3/15 17:08 | 1/31/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | P | 23 | 2.28 | 33 | 10 | 59 | 26 | D | 331 | 42 | 81 | 37 | 30 | 20 | 5 | 1 | 3 | 7 | 18 | 7 | 60 | -36 |
8/4/14 15:18 | 7/31/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | P | 20 | 2.28 | 14 | 9 | 117 | 17 | D | 95 | 59 | -22 | -1 | -15 | -5 | -6 | -5 | 3 | 2 | 14 | 32 | 81 | 184 |